Analysed 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) News Sources
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
02-04-2026
yahoo.com
Infrastructure Capital and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
02-04-2026
yahoo.com
60 Degrees Pharmaceuticals Inc. (SXTP) Upgraded to Buy: Here's What You Should Know
03-04-2026
yahoo.com
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
15-04-2026
yahoo.com
60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis
26-05-2026
yahoo.com
60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement
11-06-2026
yahoo.com
60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue
01-07-2026
yahoo.com
What is the current price of 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ)?
The current price of 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) is $0.029.
60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) absolute price change since previous trading day?
The absolute price change of 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) since the previous trading day is $-0.0008.
60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) percentage price change since previous trading day?
The percentage price change of 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) since the previous trading day is -2.6846%.
What is the most recent average sentiment score for 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ)?
The most recent average sentiment score for 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) is 64 out of 100.
What is the most recent average sentiment for 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ)?
The most recent sentiment for 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) is .
SEC-8K** Filing Available For 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.